Large-scale testing (Phase 3)Study completedNCT05767021
What this trial is testing
Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 172